Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Proposed Disposal

11 Dec 2012 07:00

RNS Number : 1974T
Ovoca Gold PLC
11 December 2012
 

Ovoca Gold plc ("Ovoca" or the "Company")

Disposal of Olcha Gold-Silver deposit ("Olcha")

Ovoca is pleased to announce that it has entered into a conditional legal agreement to sell its 100% interest in its subsidiary Olymp Limited, which holds a mining and exploration license for the Olcha gold-silver deposit, to a subsidiary of Polymetal International plc ("Polymetal") (the "Proposed Disposal"). The consideration payable under the Proposed Disposal comprises 775,000 Polymetal ordinary shares which, as of the close of business on 10 December 2012, gives a total consideration value of approximately £8.4 million (US$13.5 million).

Olcha is an epithermal gold-silver deposit that covers 2.5 square kilometres on Ovoca's Rassoshinskaya licence in the north eastern part of the Magadan Region about 200 kilometres from the town of Seimchan.

Polymetal is a leading gold and silver mining group operating in Russia and Kazakhstan whose ordinary shares are listed on the London Stock Exchange and is a member of the FTSE 100. Olcha is located approximately 215 km from the Lunnoye processing plant and 230 kilometers from the Kubaka processing plant, which belong to Polymetal's Dukat and Omolon processing hubs respectively.

Following completion of the Proposed Disposal, Ovoca will continue to develop its projects - Rassoshinskaya and Stakhanovsky. It is the Board's current intention to retain the Polymetal common shares as a medium term investment.

The Proposed Disposal constitutes a transaction which is classified as a fundamental change of business under the AIM Rules and the ESM Rules. The Board for this reason is required to issue a circular setting out the reasons for the Proposed Disposal and to seek Shareholder approval to the Proposed Disposal at an extraordinary general meeting ("EGM"). It is expected that the circular will shortly be posted to shareholders and that the EGM will occur in mid-January 2013.

Kirill Golovanov, Ovoca's CEO, commented "We are pleased to have agreed this transaction with Polymetal which allows value to be realized from the Olcha deposit for Ovoca shareholders. We remain focused on developing our business, in particular bringing our Stakhanovsky project into production. Following completion, our cash and investments will be approximately US$48 million."

Contacts:

 

Ovoca Gold Plc

Kirill Golovanov +7 495 916 6029

 

Davy - NOMAD, ESM Adviser and Joint Broker

John Frain/Daragh O'Reilly +353 1 679 6363

 

Fairfax I.S. PLC - Joint Broker

Ewan Leggat/Laura Littley +44 207 598 5368

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUROWRUAAUAAA
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.